封面圖片

The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review

Background: Immune checkpoint inhibitors (ICIs) have evolved for the treatment of solid tumors. In addition to the efficacy of ICIs for cancer, the adverse events (AEs) of ICIs are also noteworthy for gradually more extensive clinical use.Objective: To conduct a systematic review and network meta-an...

Saved in:

書目詳細資料
Main Authors:	Qing-Qing Chai (Author), Jiang-Yang Du (Author), Jun Zhu (Author), Bin Wu (Author)
格式:	圖書
出版:	Frontiers Media S.A., 2019-10-01T00:00:00Z.
主題:	article
在線閱讀:	Connect to this object online.
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Immune Checkpoint Inhibitors in Melanoma: Review and Update
由: Eugénia Matos Pires, et al.
出版: (2018)

Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis
由: Feng Sheng, et al.
出版: (2023)

Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
由: Jing Yu, et al.
出版: (2022)

Efficacy of immune checkpoint inhibitors in different types of melanoma
由: Ernesto Rossi, et al.
出版: (2021)

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
由: Ivy Riano, et al.
出版: (2023)

Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas
由: Amrita Ladwa, et al.
出版: (2024)

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
由: Virginia Ferraresi, et al.
出版: (2022)

Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy with Immune Checkpoint Inhibitors
由: Eugénia Matos Pires, et al.
出版: (2018)

Obesity paradox in patients with non‐small cell lung cancer undergoing immune checkpoint inhibitor therapy
由: Ji Hyun Lee, et al.
出版: (2023)

Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer
由: Aram A. Musaelyan, et al.
出版: (2024)

Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review
由: Sara Maria Majernikova
出版: (2024)

Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis
由: Zijing Liu, et al.
出版: (2023)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
由: Jie Yao, et al.
出版: (2024)

Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials
由: Weidong Zhang, et al.
出版: (2021)

Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma
由: Rita Pimenta, et al.
出版: (2021)

GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment
由: Tong Q, et al.
出版: (2023)

First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress
由: Zhangfeng Huang, et al.
出版: (2020)

Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer
由: Uiju Cho, et al.
出版: (2024)

Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC
由: Wei Chong, et al.
出版: (2021)

Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
由: Yi Wang, et al.
出版: (2024)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
由: Yuchun Niu, et al.
出版: (2020)

The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
由: Xilin Hu, et al.
出版: (2021)

Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis
由: Yue Zhang, et al.
出版: (2023)

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer
由: Dantong Sun, et al.
出版: (2020)

Resistance to immune checkpoint inhibitors in gastric cancer
由: Kai Liu, et al.
出版: (2023)

Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients
由: Xiaohong Xie, et al.
出版: (2023)

Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis
由: Yu Lu, et al.
出版: (2023)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
由: Yang Wen, et al.
出版: (2021)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
由: Jii Bum Lee, et al.
出版: (2021)

Immune Checkpoint Inhibitors New Insights and Recent Progress
出版: (2023)

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
由: Melissa Sarver, et al.
出版: (2022)

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
由: Yantao Xu, et al.
出版: (2022)

Immune Checkpoint Inhibitor-Associated Systemic Sclerosis in the Treatment of a Small Cell Lung Cancer Patient with Durvalumab: A Case Report
由: Li DH, et al.
出版: (2024)

The predictive value of tumor mutation burden for immune checkpoint inhibitors therapy in non-small cell lung cancer is affected by patients' age
由: Yongfeng Wu, et al.
出版: (2020)

Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report
由: Cheng Fang, et al.
出版: (2019)

A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors
由: Oren Levine, et al.
出版: (2017)

The gut microbiota and immune checkpoint inhibitors
由: Audrey Humphries, et al.
出版: (2018)

Cardiovascular complications of immune checkpoint inhibitors
由: A. A. Kulievа, et al.
出版: (2020)

Immune Checkpoint Inhibitors and Lupus Erythematosus
由: Hans Vitzthum von Eckstaedt, et al.
出版: (2024)

Risk Factors and Prognostic Analysis of Immune Checkpoint Inhibitor-Related Colitis in Lung Cancer
由: Wang S, et al.
出版: (2024)